Literature DB >> 29408216

Cervical Cancer Screening: What's New? Updates for the Busy Clinician.

Salina Zhang1, Megan McNamara2, Pelin Batur3.   

Abstract

In the United States, 12,000 women are diagnosed with cervical cancer each year, even though the screening for this disease is safe and effective. There are 3 types of screening options available: cervical cytology (Papanicolaou or "Pap" test), Pap/HPV (human papillomavirus) co-test, and HPV-only test. With simplified options such as HPV-only screening, providers who have been reluctant to incorporate cervical cancer screening into their primary care practice may feel more comfortable with offering these services to women. In this article we review the different cervical cancer screening options that are now available and summarize the various changes in guidelines over the last decade.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Cervical cancer screening; Human papillomavirus–only screening

Mesh:

Year:  2018        PMID: 29408216     DOI: 10.1016/j.amjmed.2018.01.020

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

1.  The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix.

Authors:  Bohan Li; Ling Zhang; Jianguo Zhao; Guichun Tan; Wenwen Zhang; Na Zhang; Jing Tian; Pengpeng Qu
Journal:  Infect Agent Cancer       Date:  2019-06-28       Impact factor: 2.965

2.  The Clinical Significance and Biological Function of PCDH7 in Cervical Cancer.

Authors:  Shitong Zhang; Xianhu Fu
Journal:  Cancer Manag Res       Date:  2021-05-12       Impact factor: 3.989

3.  Clinical Effects of Chinese Herbal Decoction Combined with Basic Chemoradiotherapy and Nursing Intervention in the Treatment of Cervical Cancer and the Effect on Serum CEA, CA125, and TNF-α Levels.

Authors:  Lizhen Gao; Jia Lv; Linlin Hou; Yuchao Yuan; Qiuhua Wan
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-23       Impact factor: 2.629

4.  MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.

Authors:  RongXin Xiao; Hong Wang; Biao Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Hypoxia Enhances HIF1α Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells.

Authors:  Jing Xiong; Meifang Nie; Chun Fu; Xiaoshan Chai; Yongjing Zhang; Ling He; Shujuan Sun
Journal:  Stem Cells Int       Date:  2022-03-05       Impact factor: 5.443

6.  Impact of prior underinsurance on cervical cancer screening among Davidson County, Tennessee, women diagnosed with invasive cervical cancer, 2008-2018.

Authors:  Emmanuel N S Sackey; Manideepthi Pemmaraju; Marie R Griffin; Jessica L Castilho
Journal:  BMC Womens Health       Date:  2022-03-12       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.